170 related articles for article (PubMed ID: 12043903)
1. The role of Tc-99m sestamibi imaging in predicting clinical response to chemotherapy in lung cancer.
Dirlik A; Burak Z; Goksel T; Erinc R; Karakus H; Ozcan Z; Veral A; Ozhan M
Ann Nucl Med; 2002 Apr; 16(2):103-8. PubMed ID: 12043903
[TBL] [Abstract][Full Text] [Related]
2. Tc-99m MIBI SPECT in prediction of prognosis in patients with small cell lung cancer.
Akgun A; Cok G; Karapolat I; Goksel T; Burak Z
Ann Nucl Med; 2006 May; 20(4):269-75. PubMed ID: 16856570
[TBL] [Abstract][Full Text] [Related]
3. Technetium-99m-MIBI uptake in small cell lung cancer.
Bom HS; Kim YC; Song HC; Min JJ; Kim JY; Park KO
J Nucl Med; 1998 Jan; 39(1):91-4. PubMed ID: 9443743
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m methoxyisobutylisonitrile chest imaging for small-cell lung cancer. Relationship to chemotherapy response (six courses of combination of cisplatin and etoposide) and p-glycoprotein or multidrug resistance related protein expression.
Kao A; Shiun SC; Hsu NY; Sun SS; Lee CC; Lin CC
Ann Oncol; 2001 Nov; 12(11):1561-6. PubMed ID: 11822755
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of chest single photon emission computed tomography with technetium-99m methoxyisobutylisonitrile to predict taxol based chemotherapy response in advanced non-small cell lung cancer.
Shih CM; Hsu WH; Huang WT; Wang JJ; Ho ST; Kao A
Cancer Lett; 2003 Sep; 199(1):99-105. PubMed ID: 12963129
[TBL] [Abstract][Full Text] [Related]
6. TC-99m MIBI SPECT imaging in patients with lung carcinoma: is it a functional probe of multidrug resistance genes?
Ak I; Gülbaş Z; Ocak S; Kaya E; Alataş F; Vardareli E; Metintaş M
J Comput Assist Tomogr; 2007; 31(5):795-9. PubMed ID: 17895794
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m-hexakis-2-methoxyisobutylisonitrile scintigraphy and multidrug resistance-related protein expression in human primary lung cancer.
Duan XY; Wang JS; Liu M; Guo YM
Ann Nucl Med; 2008 Jan; 22(1):49-55. PubMed ID: 18250987
[TBL] [Abstract][Full Text] [Related]
8. 99mTc-MIBI SPET in non-small cell lung cancer in relationship with Pgp and prognosis.
Yüksel M; Cermik TF; Doğanay L; Karlikaya C; Cakir E; Salan A; Berkarda S
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):876-81. PubMed ID: 12111127
[TBL] [Abstract][Full Text] [Related]
9. Semi-quantitative assessment of 99Tcm-sestamibi uptake in lung cancer: relationship with clinical response to chemotherapy.
Ceriani L; Giovanella L; Bandera M; Beghe B; Ortelli M; Roncari G
Nucl Med Commun; 1997 Nov; 18(11):1087-97. PubMed ID: 9423210
[TBL] [Abstract][Full Text] [Related]
10. Expression of multidrug resistance protein and messenger RNA correlate with (99m)Tc-MIBI imaging in patients with lung cancer.
Zhou J; Higashi K; Ueda Y; Kodama Y; Guo D; Jisaki F; Sakurai A; Takegami T; Katsuda S; Yamamoto I
J Nucl Med; 2001 Oct; 42(10):1476-83. PubMed ID: 11585860
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of Tc-99m MIBI and TI-201 SPECT in predicting chemotherapeutic response in non-small-cell lung cancer.
Nishiyama Y; Yamamoto Y; Satoh K; Ohkawa M; Kameyama K; Hayashi E; Fujita J; Tanabe M
Clin Nucl Med; 2000 May; 25(5):364-9. PubMed ID: 10795697
[TBL] [Abstract][Full Text] [Related]
12. Dipyridamole modulated Tc-99m sestamibi lung SPECT in small cell lung cancer.
Bom HS; Lim SC; Kim YC; Song HC; Min JJ; Jeong HJ; Kim JY; Lee J; Park KO
Clin Nucl Med; 1999 Feb; 24(2):97-101. PubMed ID: 9988065
[TBL] [Abstract][Full Text] [Related]
13. Using technetium-99m methoxyisobutylisonitrile lung single-photon-emission computed tomography to predict response to chemotherapy and compare with P-glycoprotein expression in patients with untreated small cell lung cancer.
Changlai SP; Tsai CS; Ding HJ; Huang WT; Kao A; Hsu WH
Med Oncol; 2003; 20(3):247-53. PubMed ID: 14514974
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of technetium-99m-sestamibi and thallium-201 SPECT in predicting chemotherapeutic response in small cell lung cancer.
Yamamoto Y; Nishiyama Y; Satoh K; Takashima H; Ohkawa M; Fujita J; Kishi T; Matsuno S; Tanabe M
J Nucl Med; 1998 Sep; 39(9):1626-9. PubMed ID: 9744357
[TBL] [Abstract][Full Text] [Related]
15. Predicting chemotherapy response to paclitaxel-based therapy in advanced non-small-cell lung cancer (stage IIIb or IV) with a higher T stage (> T2). Technetium-99m methoxyisobutylisonitrile chest single photon emission computed tomography and P-glycoprotein express ion.
Hsu WH; Yen RF; Kao CH; Shiun SC; Hsu NY; Lin CC; Lee CC
Oncology; 2002; 63(2):173-9. PubMed ID: 12239453
[TBL] [Abstract][Full Text] [Related]
16. Technetium-99m MIBI single photon emission computed tomography as an indicator of prognosis for patients with lung cancer-preliminaly report.
Komori T; Narabayashi I; Matsui R; Sueyoshi K; Aratani T; Utsunomiya K
Ann Nucl Med; 2000 Dec; 14(6):415-20. PubMed ID: 11210093
[TBL] [Abstract][Full Text] [Related]
17. 99mTc-MIBI scintigraphy as a functional method for the evaluation of multidrug resistance in breast cancer patients.
Sergieva SB; Timcheva KV; Hadjiolov ND
J BUON; 2006; 11(1):61-8. PubMed ID: 17318954
[TBL] [Abstract][Full Text] [Related]
18. Technetium-99m methoxyisobutylisonitrile chest imaging of small cell lung carcinoma: relation to patient prognosis and chemotherapy response--a preliminary report.
Kao CH; ChangLai SP; Chieng PU; Yen TC
Cancer; 1998 Jul; 83(1):64-8. PubMed ID: 9655294
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of 99mTc-sestamibi in predicting response to chemotherapy in patients with lung cancer: systematic review and meta-analysis.
Mohan HK; Miles KA
J Nucl Med; 2009 Mar; 50(3):376-81. PubMed ID: 19223414
[TBL] [Abstract][Full Text] [Related]
20. The role of technetium-99m methoxyisobutyl isonitrile scintigraphy in predicting the therapeutic effect of chemotherapy against nasopharyngeal carcinoma.
Wang XS; Zhang YJ; Liu XL; Zhou ZR; Hu CS; Eisbruch A
Cancer; 2011 Jun; 117(11):2435-41. PubMed ID: 24048791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]